| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K26531177 |
| PharmacoGx | BRD-K26531177 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A4GNT | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | AATK-AS1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | ABCC8 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | ABCD2 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | ABHD17B | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | ABL1 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | ABLIM2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | ABRA | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | AC002310.13 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | AC006386.1 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
